In a wholly new approach to cancer treatment, Northwestern University biomedical engineers have doubled the effectiveness of chemotherapy in animal experiments.

Chemoresistance remains one of the most formidable challenges in effective cancer treatment, often leading to disease relapse, metastasis, and poor patient ...

Relative to existing gene signatures, the STRESS signature better predicted not only whether cells would later develop into ...

Colon cancer remains a major global health concern, ranking third among the most diagnosed cancers and the leading cause of ...

Scancell has linked iSCIB1+ to a 69% response rate in advanced melanoma, lead | Scancell has linked iSCIB1+ to a 69% response ...

Many people with cancer experience dramatic loss of muscle and fat tissue. In many cases, even the heart muscle is affected, which further weakens the body.

Cancer cells rapidly adapt to treatments, developing resistance that makes chemotherapy less effective. Researchers used an existing anti-inflammatory drug to disrupt cancer cells’ ability to adapt by ...

CAR T-cell therapy has the potential to revolutionise how we treat certain types of cancer by genetically engineering someone’s own immune cells to attack the disease – but it is also ...

Notably, when researchers artificially removed cholesterol from cancer cells using a cholesterol-depleting drug, even the most heat-resistant cells became vulnerable to hyperthermia treatment.

They are mapping out interactions between tumour cells and the nerve cells surrounding them – and shattering the long-held belief that these are of little significance.